Clinical Trials

Home Clinical Trials Esteem Study

Now Enrolling......The use of Tecfidera (Dimethyl Fumarate) in patients with Multiple Sclerosis (Esteem Study)

Posted March 25, 2016 by

The main objective of this study is to determine the incidence, type, and pattern of serious adverse events (SAEs), including but not limited to infections, liver and kidney events, and adverse events that lead to the discontinuation of Tecfidera in patients with Multiple Sclerosis.

This study will be conduted in patients with MS who have been newly prescribed Tecfidera under routine clincal care.  


To qualify, patients must:


Patients will be followed for up to 5 years and will be asked to complete approximately 5-6 online questionnaires after their routine clinic visits.  

For more information, please contact Jeneane Henry, RN BSN, Clinical Research Nurse at 804-828-7802 or



Warren L. Felton III, MD (Principal Investigator), Dept. of Neurology at VCU

Unsong Oh, MD (Sub Investigator), Dept. of Neurology at VCU


Clinical Research Nurse / Study Coordinator:

Jeneane Henry, RN BSN, Dept. of Neurology at VCU